How Slingshot Pharma is helping virtual pharmaceutical companies gain greater control over outsourced manufacturing operations while improving collaboration with their Contract Manufacturing Organizations (CMOs).
Why Virtual Pharma Manufacturing Requires Better CMO Coordination
Pharmaceutical organizations have seen a significant shift in how they develop and manufacture drugs. Increasingly, emerging biotechnology companies and virtual pharmaceutical organizations are adopting an outsourced manufacturing model, relying on Contract Manufacturing Organizations (CMOs) to produce their drug products rather than investing in building and maintaining their own manufacturing facilities.
This approach comes with a lot of advantages, including reduced capital expenditures, access to specialized manufacturing expertise, and the flexibility to scale operations as products advance through clinical development and commercialization.
However, outsourcing an organization’s manufacturing responsibilities does not alleviate their operational or regulatory challenges. In many cases, it introduces an entirely new set of challenges.
Virtual pharmaceutical organizations must maintain visibility and oversight over their inventory, manufacturing activities, material consumption, product quality, and regulatory compliance across, what can be, multiple external manufacturing partners. Unfortunately, many organizations still manage these critical activities through disconnected spreadsheets, email communications, and manually maintained records.
The result is an environment where information is fragmented, operational decisions are delayed, and compliance risks increase. There is no “single source of truth”.
To address these challenges, Slingshot Pharma has developed a new CMO Portal designed to provide virtual (and non-virtual) pharmaceutical organizations with greater visibility, control, and accountability across their outsourced manufacturing operations.
Challenge #1: Multiple Sources of Truth Create Confusion and Inefficiency
One of the most significant challenges facing virtual pharmaceutical organizations is the lack of a centralized system for managing information exchanged with their CMOs.
Consider a typical scenario:
A virtual pharmaceutical company works with three CMOs responsible for manufacturing, packaging, and distributing its products. Each CMO maintains its own internal systems and processes for tracking inventory, production activities, and material movements.
To understand current inventory levels, the pharmaceutical company may need to request updated spreadsheets from each manufacturing partner. These files are exchanged through email, reviewed manually, and consolidated into internal tracking documents.
Meanwhile, additional emails are exchanged regarding material receipts, manufacturing schedules, inventory discrepancies, and shipment confirmations.
Before long, multiple versions of the same information exist across different spreadsheets, email attachments, and internal systems.
This creates several operational problems:
- Conflicting information: Different spreadsheets may report different inventory balances or manufacturing statuses.
- Outdated data: Information may already be obsolete by the time it reaches the virtual pharmaceutical company.
- Manual reconciliation: Employees spend valuable time comparing spreadsheets and correcting discrepancies.
- Limited accountability: Determining who requested, approved, or completed an activity can require searching through lengthy email chains.
- Delayed decision-making: Organizations cannot confidently make manufacturing or supply chain decisions without accurate, current information.
For companies managing expensive raw materials, limited production windows, and complex clinical supply chains, these inefficiencies can have significant financial and operational consequences.
How Slingshot Pharma's CMO Portal Helps
Slingshot Pharma's CMO Portal replaces fragmented communications with a centralized, shared environment where virtual pharmaceutical companies and their manufacturing partners can manage critical operational activities.
Rather than relying on multiple spreadsheets and email exchanges, organizations can initiate, approve, track, and complete manufacturing-related requests within a common platform.
The portal establishes a shared source of truth, allowing both the pharmaceutical company and its CMOs to access consistent information about inventory and operational requests.
CMOs can continue maintaining their own internal systems while using the portal to communicate essential information directly to their pharmaceutical customers.
This approach reduces administrative work, improves data consistency, and minimizes the confusion associated with managing multiple versions of the same information.
Challenge #2: Limited Inventory Visibility Across Multiple CMOs
Effective pharmaceutical inventory management requires virtual pharmaceutical organizations to know where materials are located, how much inventory is available, and when products will expire across their CMO network.
Yet many companies lack direct visibility into the inventory being managed by their manufacturing partners.
A CMO may hold raw materials, active pharmaceutical ingredients (APIs), packaging components, work-in-process materials, and finished goods on behalf of a pharmaceutical customer.
Without a centralized inventory management system, obtaining accurate information about these materials can become a time-consuming exercise.
This limited visibility can lead to:
- Unexpected material shortages that delay manufacturing.
- Excess inventory purchased because existing stock cannot be accurately verified.
- Expired materials that could have been consumed or retested before expiration.
- Difficulty identifying specific manufacturing lots across different CMO locations.
- Inaccurate inventory forecasts and replenishment decisions.
These challenges become increasingly complex as a pharmaceutical company expands its manufacturing network.
How Slingshot Pharma's CMO Portal Helps
Slingshot Pharma provides virtual pharmaceutical organizations with centralized inventory visibility across their participating CMO partners.
The portal utilizes virtual warehouse locations representing inventory held at individual CMOs, enabling the pharmaceutical company to monitor materials without physically controlling the manufacturing facilities.
Organizations can review inventory information by CMO, material status, expiration date, and lot number.
As CMOs confirm material receipts, shipments, manufacturing activities, and inventory counts, the corresponding inventory records are updated within Slingshot Pharma.
This enables organizations to better understand:
- What materials are available at each CMO.
- Which lots are approaching expiration.
- Whether sufficient components are available for upcoming manufacturing activities.
- When additional materials should be purchased or transferred.
- Where inventory discrepancies require investigation.
By providing more timely and accurate inventory information, the portal helps pharmaceutical companies reduce waste, improve replenishment planning, and minimize production delays caused by material shortages.
Challenge #3: Compliance Risks from Uncontrolled Spreadsheets and Email Communications
Pharmaceutical manufacturing operates within a highly regulated environment where data integrity, traceability, and documented controls are essential.
Virtual pharmaceutical companies remain responsible for appropriate oversight of outsourced manufacturing activities, even when those activities are performed by external CMOs.
Unfortunately, spreadsheets and email-based processes often lack the controls needed to support effective oversight.
For example, a spreadsheet containing inventory information may be modified without a reliable record of who made the change, when it occurred, or why it was necessary.
Similarly, manufacturing instructions or material disposition decisions communicated through email can become difficult to reconstruct during an audit or regulatory inspection.
These limitations create concerns involving:
- Audit trails: Inability to reliably reconstruct changes, approvals, and transactions.
- Data integrity: Increased risk of incomplete, inconsistent, or inaccurate information.
- Access controls: Limited ability to restrict activities based on individual user responsibilities.
- Process consistency: Different CMOs may follow different procedures for reporting similar activities.
- Inspection readiness: Significant time spent gathering documentation from emails, spreadsheets, and external partners.
For organizations operating under FDA current Good Manufacturing Practice (cGMP) requirements and applicable electronic records regulations, these weaknesses can introduce unnecessary compliance risk.
How Slingshot Pharma's CMO Portal Helps
Slingshot Pharma's CMO Portal introduces structured workflows and accountability into the exchange of information between pharmaceutical organizations and their manufacturing partners.
Instead of managing activities through informal email instructions, the virtual pharmaceutical company creates requests within the portal.
CMOs review those requests and formally accept or reject them, providing a reason when a request cannot be fulfilled.
The system maintains records of key activities, including who initiated a request, who approved it, and who completed the associated transaction.
These capabilities support more consistent documentation, improved traceability, and greater accountability.
By leveraging Slingshot Pharma's broader regulated ERP platform, organizations can establish a more controlled environment for managing outsourced manufacturing activities.
Importantly, the portal supports compliance oversight but does not eliminate the need for appropriate quality agreements, validated processes, and regulatory controls within the pharmaceutical company and its CMOs.
Read More: Why Pharma Companies Struggle with Compliance (And How to Fix It)
Challenge #4: Limited Control Over Day-to-Day CMO Activities
Another challenge for virtual pharmaceutical organizations is the difficulty of coordinating operational activities with external manufacturing partners.
A pharmaceutical company may need a CMO to receive incoming materials, manufacture a batch, transfer inventory to another facility, conduct an inventory count, or ship finished products to a customer.
Traditionally, these requests may be communicated through emails, purchase orders, spreadsheets, or phone calls.
Once a request is submitted, the pharmaceutical company often has limited visibility into whether it has been accepted, whether the activity has started, or when it has been completed.
This can lead to missed communications, delays, and uncertainty surrounding operational responsibilities.
How Slingshot Pharma's CMO Portal Helps
The new CMO Portal supports CMO request management through structured workflows for coordinating major activities performed by external manufacturing partners.
Request Type and how it Helps Virtual Pharma Organizations
Material Receipt
CMOs confirm incoming materials, quantities, and lot information, updating inventory records.
Shipment
Organizations request outbound shipments and receive confirmation of the lots and quantities shipped.
Inventory Transfer
Track materials moving between CMO locations, including shipment, transit, and receipt activities.
Batch Manufacturing
Request manufacturing activities and capture finished quantities, component consumption, and associated lot information.
Inventory Count
Initiate physical inventory counts and reconcile reported quantities against system balances.
Material Destruction
Manage requests to destroy designated materials and document completion.
Sampling and Testing
Coordinate sampling activities, record sampled quantities, and associate testing documentation with requests.
Through these structured workflows, virtual pharmaceutical organizations gain greater insight into what their CMOs have been asked to do, what they have accepted, and which activities have been completed.
This level of operational transparency helps reduce follow-up emails, improves coordination, and enables more proactive supply chain management.
Challenge #5: Difficulty Tracking Manufacturing Lots and Material Consumption
Lot traceability is particularly important in pharmaceutical manufacturing.
Organizations must be able to understand which raw materials and components were used in the production of specific finished product batches.
When manufacturing is outsourced, obtaining this information may require requesting batch records, reviewing spreadsheets, and manually correlating material usage across different systems.
The challenge becomes even greater when materials are transferred between multiple manufacturing locations.
Incomplete or delayed information can complicate inventory reconciliation, investigations, product traceability, and manufacturing planning.
How Slingshot Pharma's CMO Portal Helps
The CMO Portal supports structured collection of manufacturing batch information directly from participating CMOs.
When a virtual pharmaceutical company initiates a batch manufacturing request, it identifies the finished product, planned manufacturing quantity, and internal lot number.
Upon completion, the CMO provides information such as:
- Actual finished product quantity.
- CMO internal lot number.
- Product expiration date.
- Component material lots consumed.
- Quantities of each component used.
This information is used to update inventory balances and create material genealogy records within Slingshot Pharma.
By connecting manufacturing activity with inventory consumption and finished product information, the portal helps organizations maintain more complete visibility into their outsourced production processes.
This is particularly valuable for companies coordinating manufacturing activities across multiple external partners.
Read Also: How Pharma ERP Improves Batch Manufacturing, Lot Tracking, and Traceability
Challenge #6: Inventory Discrepancies Can Go Undetected
Even when organizations receive regular inventory reports from their CMOs, discrepancies can occur.
Materials may be consumed during manufacturing, damaged, sampled, transferred, or otherwise adjusted without the pharmaceutical company's internal records being updated promptly.
Over time, differences between reported inventory and actual physical inventory can become significant.
These discrepancies may not be discovered until a manufacturing order cannot be fulfilled or an unexpected shortage occurs.
How Slingshot Pharma's CMO Portal Helps
Slingshot Pharma's CMO Portal includes inventory count and reconciliation capabilities designed to improve inventory accuracy.
Virtual pharmaceutical companies can request physical inventory counts from their CMO partners.
CMOs enter actual count quantities through the portal, and the pharmaceutical company can review and reconcile the results within Slingshot Pharma's inventory management application.
The portal design also provides for periodic, automatically generated inventory count lists, helping organizations establish a more consistent reconciliation process.
This approach supports early identification of inventory discrepancies and reduces dependence on infrequent, manually coordinated inventory reviews.
Read Also: Top 5 Challenges in Pharmaceutical Inventory Control and How to Solve Them
Challenge #7: CMOs Are Already Managing Multiple Customers and Systems
While virtual pharmaceutical companies benefit from greater operational visibility, CMOs face challenges of their own.
A single CMO may support dozens of pharmaceutical customers, each with different reporting requirements, communication methods, and software systems.
Requiring a CMO to learn and maintain another complex platform can create additional administrative work and discourage adoption.
For a CMO Portal to succeed, it must deliver value to the pharmaceutical company without placing an unreasonable burden on its manufacturing partners.
How Slingshot Pharma's CMO Portal Helps
A key design objective of Slingshot Pharma's CMO Portal is to minimize the effort required from participating CMOs.
The portal emphasizes straightforward workflows that allow manufacturing partners to respond to requests efficiently.
For many activities, including accepting requests, confirming shipments, and acknowledging inventory transfers, the intended process requires only a few clicks.
CMOs receive email notifications when requests are awaiting review and can access the portal to accept or reject them.
More detailed activities, such as material receipts and batch manufacturing confirmations, use structured entry screens designed to simplify the collection of required information.
By reducing repetitive communication and manual reporting, the portal is intended to benefit both the pharmaceutical company and its manufacturing partners.
And when a CMO cannot participate directly, the virtual pharmaceutical organization can enter information on its behalf, maintaining centralized records without requiring every partner to change its existing processes.
A More Connected Approach to Outsourced Pharma Manufacturing
The traditional relationship between virtual pharmaceutical companies and their CMOs has often been characterized by fragmented information, reactive communication, and limited operational transparency.
As pharmaceutical supply chains become increasingly complex, these approaches are becoming more difficult to sustain.
Organizations need more than periodic spreadsheets and email updates. They need timely access to inventory information, structured processes for coordinating manufacturing activities, and reliable records that support operational accountability.
Equally important, they need technology that recognizes the realities of outsourced manufacturing.
CMOs must be able to continue operating their own businesses efficiently, while pharmaceutical customers require the information necessary to manage their supply chains and maintain appropriate oversight.
The most effective solution is not necessarily to replace every CMO's existing systems. Instead, it is to create a connected environment where critical information can be exchanged consistently and efficiently.
How Slingshot Pharma’s CMO Portal Supports Virtual Pharma Operations
Slingshot Pharma's new CMO Portal is designed specifically to address the operational challenges of virtual pharmaceutical manufacturing.
By combining centralized inventory visibility, structured CMO request management, lot-level traceability, inventory reconciliation, and auditable transaction records, the portal helps bridge the information gap between pharmaceutical organizations and their outsourced manufacturing partners.
Rather than relying on disconnected spreadsheets and lengthy email exchanges, virtual pharmaceutical companies can manage critical manufacturing activities through a shared platform.
The result is a more connected and transparent outsourced manufacturing model that can help organizations:
- Improve operational visibility across multiple CMOs and inventory locations.
- Reduce administrative overhead by minimizing spreadsheets, emails, and manual data entry.
- Strengthen compliance oversight through structured workflows and documented accountability.
- Improve inventory accuracy with timely transaction updates and periodic reconciliation.
- Reduce manufacturing disruptions through better material availability and replenishment planning.
- Enhance lot traceability by connecting material consumption with finished product manufacturing.
- Build stronger CMO relationships through simpler communication and clearer operational expectations.
For virtual pharmaceutical organizations, outsourcing manufacturing should not mean sacrificing visibility or control.
With Slingshot Pharma's CMO Portal, pharmaceutical companies can gain the insight they need to manage outsourced manufacturing operations more effectively, while allowing their CMOs to focus on what they do best: manufacturing quality pharmaceutical products.
Ready to Gain Greater Visibility into Your CMO Operations?
Discover how Slingshot Pharma's purpose-built pharmaceutical ERP solution and new CMO Portal can help your organization eliminate disconnected spreadsheets, streamline collaboration with manufacturing partners, and strengthen control over your pharmaceutical supply chain.
Contact Slingshot Pharma today to schedule a demonstration and learn how our CMO Portal can support your virtual pharmaceutical operations.
.png)